1. Sampliner RE. Updated guidelines for the diagnosis,surveillance, and therapy of Barrett’s esophagus. Am J Gastroenterol 2002;97:1888-95.
2. Sharma P. et al. Real-time Increased Detection of Neoplastic Tissue in Barrett’s Esophagus with probe- based Confocal Laser Endomicroscopy: Final Results of a Multi-center Prospective International Randomized Controlled Trial. Gastrointestinal Endoscopy, 2011.
3. Bertani H. et al. Improved Detection of Incident Dysplasia by Probe-Based Confocal Laser Endomicroscopy in a Barrett’s Esophagus Surveillance Program. Digestive Diseases and Sciences, 2013.
4. Konda V.J. et al. Confocal laser endomicroscopy: potential in the management of Barrett’s esophagus. Diseases of the Esophagus, 2010.
5. Johnson E.A. et al. Probe-Based Confocal Laser Endomicroscopy to Guide Real-Time Endoscopic Therapy in Barrett’s Esophagus with Dysplasia. Case Reports in Gastroenterology, 2012.
a. Traditional pathological examination of tissue samples remains the “gold standard” for evaluating tissue abnormalities and the presence of cancer. Targeted biopsy has been demonstrated to facilitate this traditional sampling and under certain conditions even potentially reduce the need for traditional examination.
b. The effectiveness of the Cellvizio system for assisting physicians in detecting cancer has not been evaluated by the U.S. FDA. These statements are not intended as claims of effectiveness or safety for these specific indications.
c. The Cellvizio Systems ability to help facilitate cancer detection is dependent upon the skill and experience of the physician using the system.